IRIS
SERRETTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.849
AS - Asia 1.110
EU - Europa 562
SA - Sud America 360
AF - Africa 38
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.927
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.805
SG - Singapore 370
BR - Brasile 284
HK - Hong Kong 191
CN - Cina 190
IT - Italia 157
TR - Turchia 132
IE - Irlanda 131
VN - Vietnam 92
FR - Francia 69
DE - Germania 55
GB - Regno Unito 38
AR - Argentina 28
NL - Olanda 25
IN - India 23
MX - Messico 22
PL - Polonia 20
EC - Ecuador 18
BD - Bangladesh 16
CA - Canada 16
ZA - Sudafrica 16
AT - Austria 14
FI - Finlandia 12
ID - Indonesia 12
IQ - Iraq 12
CO - Colombia 10
IL - Israele 10
PY - Paraguay 8
SA - Arabia Saudita 8
SE - Svezia 8
AU - Australia 6
JP - Giappone 6
MA - Marocco 6
PK - Pakistan 6
UZ - Uzbekistan 6
PE - Perù 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
KR - Corea 4
MY - Malesia 4
RU - Federazione Russa 4
TN - Tunisia 4
BE - Belgio 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ES - Italia 3
GR - Grecia 3
KE - Kenya 3
LB - Libano 3
NP - Nepal 3
PH - Filippine 3
PS - Palestinian Territory 3
PT - Portogallo 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
LV - Lettonia 2
PA - Panama 2
TH - Thailandia 2
UA - Ucraina 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
MN - Mongolia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.927
Salva come PNG Salva come JPEG
Città #
Dallas 896
Hong Kong 188
San Jose 174
Singapore 154
Dublin 131
Ashburn 121
The Dalles 95
Istanbul 66
Boardman 61
Beijing 56
Chicago 56
Santa Clara 48
Ankara 43
Ho Chi Minh City 32
Los Angeles 26
São Paulo 24
Hanoi 21
Frankfurt am Main 18
Warsaw 17
Hillsboro 16
Rome 15
New York 14
Amsterdam 13
Council Bluffs 12
Munich 12
Rio de Janeiro 12
Naples 11
Chennai 10
Helsinki 10
Milan 10
San Francisco 10
Mexico City 9
Vienna 9
Brasília 8
Paris 8
York 8
Haiphong 7
Johannesburg 7
Mishmar HaShiv`a 7
Assago 6
Brooklyn 6
Curitiba 6
Fortaleza 6
Nuremberg 6
Orem 6
Reston 6
Stockholm 6
Tashkent 6
Düsseldorf 5
Guangzhou 5
Guayaquil 5
Limburg an der Lahn 5
Nijmegen 5
Quito 5
Recife 5
Rimini 5
Belo Horizonte 4
Boston 4
Catania 4
Divinópolis 4
London 4
Seoul 4
Sydney 4
Thái Bình 4
Asunción 3
Athens 3
Biên Hòa 3
Brno 3
Buenos Aires 3
Bursa 3
Cairo 3
City of London 3
Dammam 3
Denizli 3
Dhaka 3
Erbil 3
Ferrara 3
Goiânia 3
Hangzhou 3
Lauterbourg 3
Lima 3
Lyon 3
Manchester 3
Modena 3
New Delhi 3
Ottawa 3
Petrópolis 3
Portsmouth 3
Praia Grande 3
Ragalna 3
Rio das Ostras 3
Seattle 3
St Albans 3
São José dos Campos 3
Thomaston 3
Tokyo 3
Uberlândia 3
Vitória da Conquista 3
Álvaro Obregón 3
Ambato 2
Totale 2.668
Salva come PNG Salva come JPEG
Nome #
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 554
Understanding and treating postpartum depression: a narrative review 101
Depression: Understanding and Managing Antidepressant Side Effects 93
A comprehensive overview of post-stroke depression treatment options 86
Treatment-Resistant Depression: When and How Should It Be Referred? 80
Neurological, Metabolic, and Psychopathological Correlates of Lifetime Suicidal Behaviour in Major Depressive Disorder without Current Suicide Ideation 77
Suicide ideation and male-female differences in major depressive disorder 74
Mapping genomic loci implicates genes and synaptic biology in schizophrenia 73
Resistance to Change from a Psychological Perspective 72
Mental fatigue in individuals with psychiatric disorders: a scoping review 70
Anhedonia and Depressive Disorders 70
A Clinically Oriented Review of New Antipsychotics for Schizophrenia 67
Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex 66
GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors 65
Anhedonia: Current and future treatments 63
Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting 63
A Critical View on New and Future Antidepressants 60
Genetic and clinical characteristics of treatment-resistant depression using primary care records in two {UK} cohorts 60
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? 59
Age as a moderating factor of treatment resistance in depression 58
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics 56
Genetic factors and symptom dimensions associated with antidepressant treatment outcomes: clues for new potential therapeutic targets? 56
Expanding treatment domains across psychiatric disorders 56
Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology 56
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors 55
Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis 55
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors 54
[Assisted suicide for patients suffering from severe depression. An unacceptable option that psychiatrists must fight with all their strength.] 54
Transdiagnostic Effects of Schizophrenia Polygenic Scores on Treatment Outcomes in Major Psychiatric Disorders 54
The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence 54
Anhedonia is associated with a specific depression profile and poor antidepressant response 54
Antidepressant emergent mood switch in major depressive disorder: onset, clinical correlates and impact on suicidality 53
Antidepressant treatment in complex clinical pictures 53
Exploring the use of immunomethylomics in the characterization of depressed patients: A proof-of-concept study 52
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues 51
Understanding mood disorder treatments 51
Multimodal brain-derived subtypes of Major depressive disorder differentiate patients for anergic symptoms, immune-inflammatory markers, history of childhood trauma and treatment-resistance 49
Polygenic risk scores for mood and related disorders and environmental factors: Interaction effects on wellbeing in the UK biobank 49
The pharmacological management of treatment-resistant depression: what does the future hold? 49
Genomics yields biological and phenotypic insights into bipolar disorder 49
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges 48
Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies 48
Focus on neurodevelopmental conditions and antipsychotics prescription patterns 47
Volumetric absorptive microsampling for the therapeutic drug monitoring of psychiatric patients treated with cariprazine 47
Investigation of Psychoactive Medications: Challenges and a Practical and Scalable New Path 47
Stroke, COVID-19, and other somatic aspects of psychiatric disorders treatments 45
Afternoon Keynote Genetic and Clinical Predictors of Antidepressant Response 43
Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient 42
The clinical perspective on late-onset depression in European real-world treatment settings 41
Mirtazapine blood levels and antidepressant response 37
Mood disorders and somatic comorbidities 34
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis 34
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder 34
Psychological impact of neovagina creation and uterus transplantation in the patients affected from Mayer–Rokitanski–Kuster–Hauser syndrome: A narrative review 33
Modulating factors in mood disorders treatment 32
Serum Biomarkers of Vascular Dysfunction, Neuropsychiatric Symptoms, and Clinical Severity of Alzheimer’s Disease: A Cross-sectional Study 16
Shared genetics and causal relationship between sociability and the brain's default mode network 16
Polygenic scores and antidepressant treatment outcomes in major depression: a critical integrative review 16
The Genetic Landscape of Kynurenine Predicts Neurovascular Pathology and Disrupted White Matter Integrity in Patients With Mood Disorders 15
Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis 15
Insulin resistance and poorer treatment outcomes in depression: Evidence from UK Biobank primary care data 15
Passive suicide ideation in major depressive disorder: prognostic role and effect of antidepressant treatment 15
Unlocking the Link Between Gut Microbiota and Psychopathological Insights in Anorexia Nervosa: A Systematic Review 15
Telomere length and mitochondrial DNA copy number in association with trauma-focused psychotherapy efficacy 14
Further evidence of depressive symptomatology profile predicting treatment outcome 14
Mild motor signs and depression: more than just medication side effects? 14
Local patterns of genetic sharing between neuropsychiatric and insulin resistance-related conditions 14
The impact of depression on functioning: Relation to medication response and other predictors 13
The Multifaceted Etiology of Mental Disorders With a Focus on Trace Elements, a Review of Recent Literature 13
Oropharyngeal microbiota in patients with psychotic disorders: A scoping review on compositional and functional alterations 13
Rapid-acting NMDA and GABAergic Modulators in Mood Disorders: From Synaptic Mechanisms to Clinical Practice 13
Clinical predictors of treatment resistant depression 13
Innovations and challenges in antipsychotic treatments and external modulating factors 13
Fine-mapping genomic loci refines bipolar disorder risk genes 12
A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon Europe 11
Polygenic predisposition to transdiagnostic symptom dimensions and treatment outcomes across psychiatric disorders 11
Moving toward precision and personalized treatment strategies in psychiatry 11
Challenging the impostor: a scoping review of the pharmacological management of Capgras syndrome in Parkinson’s disease and Lewy bodies dementia 10
The genetics of treatment-resistant depression: controversies and perspectives 10
Differences in emotion recognition between nonimmersive versus immersive virtual reality: Preliminary findings in schizophrenia and bipolar disorder 10
Neurological features in psychiatric disorders: biomarkers, comorbidity, and clinical translation 10
Underinvestigated aspects of depression treatment: comorbidity, quality-of-life, and novel adjuncts 10
Neuropsychiatric Symptoms and Alzheimer’s Disease Severity. A Focus on Sex-Differences 9
Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis 9
Recommendations for defining treatment outcomes in major psychiatric disorders using real-world data 9
Unsolved Issues in Anhedonia: A Call for Targeted Inquiry 9
Defining suicidality phenotypes for genetic studies: perspectives of the Psychiatric Genomics Consortium Suicide Working Group 9
Factors associated with drug–drug interactions involving citalopram in the UK Biobank 9
Defining and assessing international classification of disease suicidality phenotypes for genetic studies 9
New Genomics Discoveries Across the Bipolar Disorder Spectrum Implicate Neurobiological and Developmental Pathways 8
Treatment options for depression in Parkinson's disease: a mini-review 8
Schizophrenia Genetics Modulates Clinical Depressive Features 8
Symptom networks in major depressive disorder and treatment response: special focus on TRD 7
Asenapine for aggressive behaviours in psychiatric disorders: a systematic review of efficacy and real-world effectiveness 7
Totale 4.036
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.629
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024229 0 0 0 0 0 0 0 17 30 37 80 65
2024/2025917 45 26 39 31 86 55 33 41 178 180 144 59
2025/20262.890 138 418 738 252 84 172 201 331 292 264 0 0
Totale 4.036